tiprankstipranks
Trending News
More News >
Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ:TELO
US Market

Telomir Pharmaceuticals, Inc. (TELO) Cash flow

Compare
205 Followers

Telomir Pharmaceuticals, Inc. Cash Flow

TELO's free cash flow for Q3 2025 was $-927.26K. For the 2025 fiscal year, TELO's free cash flow was decreased by $-1.21M and operating cash flow was $-927.26K. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -5.07M$ -3.86M$ -468.66K$ -119.40K
Investing Cash Flow
$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow
$ 6.34M$ 3.86M$ 470.08K$ 119.40K
End Cash Position
$ 1.27M$ 1.23K$ 1.42K$ 0.00
Free Cash Flow
$ -5.07M$ -3.86M$ -468.66K$ -119.40K
Currency in USD

Telomir Pharmaceuticals, Inc. Cash Flow